Purdue Pharma L.P. Announces Hire of Carrie Chomiak to Lead Over-the-Counter Franchise
April 21 2017 - 08:00AM
Business Wire
Purdue Pharma L.P. today announced the hire of Carrie Chomiak as
the business lead for the company’s over-the-counter (OTC) product
franchise. Chomiak will have executive ownership for all OTC
brands, which include the Betadine® microbicide antiseptics,
Slow-Mag® magnesium chloride supplements, Senokot® laxative and
Colace® stool softener product lines.
This Smart News Release features multimedia.
View the full release here:
http://www.businesswire.com/news/home/20170421005077/en/
Carrie Chomiak, head of over-the-counter
products franchise, Purdue Pharma L.P. (Photo: Business Wire)
“Carrie brings very strong sales and marketing leadership skills
and experience in consumer brands to optimize our existing
over-the-counter products as well as to partner with our business
development team to accelerate the expansion of our OTC portfolio,”
said Mark Timney, president and chief executive officer, Purdue
Pharma L.P. “Her proven record of accomplishment for delivering
exceptional commercial business results with iconic consumer brands
gives us the confidence that she is the right person for this
position.”
Chomiak joins Purdue Pharma after more than 15 years of success
in the marketing and selling of consumer health and wellness brands
at Pfizer Consumer Healthcare, previously Wyeth Consumer Healthcare
(PCH). At PCH she most recently served as a member of the U.S.
executive leadership team, and led the U.S. digestive health
franchise which included the Nexium 24HR switch from prescription
to over-the-counter status and the commercial management of the
Preparation H brand. During her tenure at PCH Carrie additionally
held commercial leadership roles within the nutrition, respiratory,
pain and personal care franchises, which included well-known brands
such as Centrum, Caltrate, Advil, Emergen-C, Robitussin, Dimetapp
and Chapstick.
Chomiak will have executive ownership for the OTC franchise and
be responsible for ensuring the successful development and
commercialization of Purdue’s complete line of OTC assets, which
includes leading the corporate long-range plan development and
general management of the short-term business. This includes
overseeing the development and implementation of brand equity and
integrated communication elements, discovery of new relevant
consumer insights, monitoring of business performance and
evaluating new business opportunities for this franchise.
“Purdue’s over-the-counter products are well-established, legacy
brands that are trusted by hospitals and consumers,” said Chomiak.
“I look forward to contributing to the organization's ongoing
evolution and creating value both organically and through strategic
business development initiatives.”
Chomiak earned a bachelor of science degree in marketing from
Montclair State University in Montclair, N.J.
ABOUT PURDUE PHARMA L.P.
Purdue Pharma is a privately-held pharmaceutical company and is
part of a global network of independent associated companies known
for pioneering research in chronic pain and opioids with abuse
deterrent properties. The company’s leadership and employees are
committed to providing healthcare professionals, patients and
caregivers quality products and educational resources to support
their proper use. With Purdue Pharma’s expertise in drug
development, commercialization and life-cycle management, the
company is diversifying in high-need areas to expand through
strategic acquisitions and creative partnerships. For more
information, please visit www.purduepharma.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170421005077/en/
Media Inquiries:Purdue Pharma L.P.Catherine London, +1
203-588-7530Corporate Communicationscatherine.london@pharma.com